EUVIMEDEUVIMED entdecken
Crossref

An Isocratic RP‐HPLC Method for Simultaneous Quantification of Nateglinide and Furosemide: Application to In Vitro Caco‐2 Intestinal Permeability Studies of Nanodrugs

Fatima Khalifa Al-Sulaiti iD, Aysegul Dogan iD, Fatma Kir iD, Selma Sahin iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Fatima Khalifa Al-Sulaiti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Pharmaceutical Technology Department, Hacettepe University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Furosemide, Nateglinide, Chromatography, Reverse-Phase, Phenylalanine. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the booming era of nanomedicines, Caco‐2 intestinal permeability experimental models allow characterizing intestinal permeabilities of nanopharmaceuticals and are conducted in the presence of cell culture media (CCM) and stabilizers. Methods for simultaneous quantification of furosemide (FRS) and nateglinide (NTG) in Caco‐2 experiments are lacking. We developed and validated a novel, simple, and practical reversed‐phase high‐performance liquid chromatography (RP‐HPLC) method with UV detection to simultaneously quantify FRS and NTG in the presence of CCM and stabilizers (Povidone K‐25, Pluronic F‐38) for Caco‐2 intestinal permeability experiments exploring nanoformulations. FRS and NTG nanosuspensions were prepared using high‐speed ultrasonic homogenization top–down technique. Caco‐2 cell culture studies were conducted. ICH Q2(R1) guideline requirements (i.e., selectivity, specificity, accuracy, precision, robustness, stability) were met. System suitability and linearity (FRS: 5.12–40.00 μg/mL; NTG: 7.31–50.00 μg/mL), with high determination coefficients (>0.999), and short retention times (FRS: 3.3 min; NTG: 5.3 min) were achieved. NTG and FRS in Caco‐2 samples were successfully simultaneously quantified, proving usefulness for nanodrug research applications. Varying stabilizers impact intestinal permeability. This work simulates pragmatic conditions, as cardiovascular patients are co‐administered these drugs, paving the pathway to using our novel method for a wide range of “bench‐to‐bedside” nanomedicine research designs to tackle the challenges of polypharmacy in this complex population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FurosemideNateglinideChromatography, Reverse-PhasePhenylalanineCyclohexanesHumansCaco-2 CellsChromatography, High Pressure LiquidReproducibility of ResultsPermeabilityLinear ModelsLimit of DetectionIntestinal AbsorptionNanoparticlesIntestinal Barrier Function

Stichwörter der Autor:innen

HPLC method development/validationfurosemideintestinal permeabilitynanodrugsnanosuspensionsnateglinide cell culture

Substanzen

FurosemideNateglinidePhenylalanineCyclohexanes

Autor:innen und Institutionen

  • Faculty of Pharmacy, Pharmaceutical Technology Department, Hacettepe University, Ankara, Türkiye.
  • Faculty of Pharmacy, Department of Analytical Chemistry, Hacettepe University, Ankara, Türkiye.

ORCID-Profile: Fatima Khalifa Al-Sulaiti, Aysegul Dogan, Fatma Kir, Selma Sahin

Zitieren

APA

Al-Sulaiti, F. K., Dogan, A., Kir, F., & Sahin, S. (2025). An Isocratic RP‐HPLC Method for Simultaneous Quantification of Nateglinide and Furosemide: Application to In Vitro Caco‐2 Intestinal Permeability Studies of Nanodrugs. Biomedical Chromatography. https://doi.org/10.1002/bmc.70229

Vancouver

Al-Sulaiti FK, Dogan A, Kir F, Sahin S. An Isocratic RP‐HPLC Method for Simultaneous Quantification of Nateglinide and Furosemide: Application to In Vitro Caco‐2 Intestinal Permeability Studies of Nanodrugs. Biomedical Chromatography. 2025. doi:10.1002/bmc.70229

BibTeX
@article{AlSulaiti2025,
  author = {Al-Sulaiti, Fatima Khalifa and Dogan, Aysegul and Kir, Fatma and Sahin, Selma},
  title = {An Isocratic RP‐HPLC Method for Simultaneous Quantification of Nateglinide and Furosemide: Application to In Vitro Caco‐2 Intestinal Permeability Studies of Nanodrugs},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70229}
}
Kostenlos starten →